AllianceBernstein
KMTS

AllianceBernstein’s Kestra Medical Technologies KMTS Stock Holding History

AllianceBernstein’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35M Sell
1,320,374
-105,681
-7% -$2.49M 0.01% 712
2025
Q4 		$37.8M Sell
1,426,055
-65,915
-4% -$1.7M 0.01% 713
2025
Q3 		$35.4M Buy
1,491,970
+179,885
+14% +$3.22M 0.01% 719
2025
Q2 		$21.8M Buy
1,312,085
+128,312
+11% +$2.8M 0.01% 873
2025
Q1 		$29.5M Buy
+1,183,773
New +$27.2M 0.01% 748

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein's KMTS Position: Q1 2026 in Review

AllianceBernstein reduced its Kestra Medical Technologies (KMTS) stake by 7.4% in Q1 2026, selling an estimated $2.49M and leaving 1,320,374 shares worth $35M. The position accounts for 0.01% of the portfolio, ranked #712.

AllianceBernstein first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $37.8M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • AllianceBernstein held 1,320,374 shares of Kestra Medical Technologies worth $35M as of Q1 2026.
  • AllianceBernstein sold 105,681 Kestra Medical Technologies shares in Q1 2026, an estimated $2.49M.
  • Kestra Medical Technologies made up 0.01% of AllianceBernstein's portfolio in Q1 2026, its #712 holding.
  • AllianceBernstein first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • AllianceBernstein's Kestra Medical Technologies position peaked at $37.8M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.